Results 11 to 20 of about 64,598 (305)

NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients

open access: yesFrontiers in Pharmacology, 2018
The aim of this study was to investigate the influence of NUDT15 R139C, thiopurine S-methyltransferase (TPMT), and 6-TGN on azathioprine (AZA) induced leukopenia in Chinese autoimmune patients. Among 87 enrolled patients, 23 (26.4%) had leukopenia.
Xiang Fei   +8 more
doaj   +2 more sources

Ceftriaxone-Induced Leukopenia During Inpatient Rehabilitation: A Case Report. [PDF]

open access: yesCureus
Ceftriaxone is a commonly used third-generation cephalosporin with a favorable safety profile and widespread use across acute and post-acute care settings.
Rivera-Amador LD   +4 more
europepmc   +2 more sources

Oral Iron Therapy-Induced Neutropenia in Patient with Iron Deficiency Anemia

open access: yesCase Reports in Oncology, 2020
Iron deficiency anemia is common and worldwide distributed, particularly among females; however, it can also occur among males. Iron deficiency anemia is commonly associated with thrombocytosis; little is known about the effect of iron therapy (oral or ...
Mohammad N. Kloub, Mohamed A. Yassin
doaj   +1 more source

Radiation-free or Chemo-free: Rethinking the Best Strategy for PD-L1-High, Unresectable Stage III NSCLC. [PDF]

open access: yesPrecis Radiat Oncol
This article discusses the emerging radiotherapy‐free and chemo‐free strategies in PD‐L1–high, unresectable stage III NSCLC, reviewing the Evolution trial and comparing it with existing treatments. We highlight the need for further research to validate these approaches and ensure safe de‐escalation without compromising ...
Xiang Y, Bi N.
europepmc   +2 more sources

DENGUE FEVER IN CHILDREN

open access: yesДетские инфекции (Москва), 2015
Currently in Russia number of cases of dengue fever in adults grows up, whereas in endemic areas, due to the wide spread of the disease is more common in children, which symptoms has its own characteristics.
N. N. Zvereva   +5 more
doaj   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Clinical Profile of Patients with Dengue: A One-year Retrospective Study at a Tertiary Care Center

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2023
Introduction: Dengue is an acute viral illness caused by the Flaviviridae RNA virus and spread by the Aedes mosquito. Being a tropical illness, knowledge of its demographic and clinical profiles and seasonal incidence can aid in the management and ...
Yoganathan CHIDAMBARAM   +3 more
doaj   +1 more source

Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction.

open access: yesPLoS ONE, 2021
BackgroundAlthough both leukocytosis and leukopenia have been considered Systemic Inflammatory Response Syndrome criteria, leukopenia is not generally considered a normal response to infection.
Samuel H Belok   +3 more
doaj   +1 more source

Síndrome de Felty e Calazar: um desafio para o reumatologista Felty's syndrome and Kala-azar: a challenge for the rheumatologist

open access: yesRevista Brasileira de Reumatologia, 2010
Os autores relatam o caso de uma paciente com artrite reumatoide que evoluiu com grave neutropenia e esplenomegalia, sendo firmado o diagnóstico de Síndrome de Felty, que posteriormente desenvolveu Calazar.
Rafaela Bicalho Viana   +4 more
doaj   +1 more source

Meta-analysis of grade ≥3 leukopenia.

open access: yes, 2023
Meta-analysis of grade ≥3 leukopenia.
Wenyuan Li (44230)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy